Trends in Stroke Prevention between 2014 and 2018 in Hospitalized Atrial Fibrillation Patients.

ABSTRACT: In recent years, significant changes in stroke prophylaxis in patients with atrial fibrillation (AF) have been observed. Non-vitamin K antagonist oral anticoagulants (NOACs) are more commonly used in the prevention of thromboembolic complications in patients with AF. The aim of the study was to evaluate recommended stroke prophylaxis in patients with AF and to identify predictors of using NOACs in patients treated with anticoagulant therapy. The present study was a retrospective, observational, single-center study which included consecutively hospitalized patients in the reference cardiology center from January 2014 to December 2018. In the study group of 4027 patients with AF, to prevent thromboembolic complications, OACs were used in 3680 patients (91.4%), an antiplatelet drug(s) was use

SUBMITTER: Bielecka B 

PROVIDER: S-EPMC7886594 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature